Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rachel Mcminn currently holds 155,100 shares of Neurogene Inc. (NGNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rachel Mcminn has been a net seller of NGNE stock. They have purchased $0 and sold $540.7K worth of shares.
Rachel Mcminn's most recent insider trade was on Feb 20, 2026, when they sold 155,100 shares at $0.00 per share.
Rachel Mcminn serves as Executive at Neurogene Inc. (NGNE). They have executed 22 insider transactions totaling $540.7K over their tenure at the company.
Rachel Mcminn holds the position of Executive at Neurogene Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Rachel Mcminn has shown a selling trading pattern, with $0 in total purchases and $540.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Rachel Mcminn was on May 1, 2015, when they sold $128.3K worth of ICPT shares. This transaction involved 503 shares at $255.12 per share.
Rachel Mcminn currently owns 155,100 shares of Neurogene Inc. (NGNE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rachel Mcminn's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rachel Mcminn has 22 Form 4 filings on record as an insider at Neurogene Inc..
Set alerts for Rachel Mcminn and 40,000+ other insiders.